Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Triethanolamine salicylate. in concentrations up to and including 20% U
Trifluoperazine or its saltsPDL I DEC / 13
Triflupromazine or its saltsPDL I DEC / 13
TrifluridinePDL I DEC / 13
Trihexyphenidyl or its saltsPDL I DEC / 13
Triiodothyropropionic acidPDL I DEC / 13
TrilostanePDL I DEC / 13
Trimebutine or its saltsPDL I DEC / 13
TrimeperidineN I JUN / 02
Trimeprazine or its saltsPDL

for human use

I DEC / 13
TrimethadionePDL I DEC / 13
Trimethaphan camsylatePDL I DEC / 13
Trimethoprim or its saltsPDL I DEC / 13
Trimetrexate or its saltsPDL I DEC / 13
Trimipramine or its saltsPDL I DEC / 13
TrioxsalenPDL I DEC / 13
Tripelennamine and its salts III SEP / 98
Triprolidine III SEP / 98
Triptorelin or its salts or derivativesPDL I DEC / 13
TroglitazonePDL I DEC / 13
Tropicamide or its saltsPDL

in preparations for parenteral or ophthalmic use, except when sold for use in diagnostic procedures to an optometrist registered in a province of Canada for human use

I DEC / 13
Tropicamide or its saltsPDL

For veterinary use

I DEC / 13
Trospium chloridePDL I DEC / 13
Trovafloxacin or its salts or derivativesPDL

including but not limited to alatrofloxacin

I DEC / 13
Trypsin U DEC / 98
Tubocurarine chloridePDL I DEC / 13
TulathromycinPDL

For veterinary use

I DEC / 13
TybamatePDL I DEC / 13
Tylosin or its salts or derivativesPDL

Including but not limited to: Tildipirosin, tilmicosin, tylvalosin

I DEC / 18
Typhoid vaccines/Salmonella Typhi vaccines I FEB / 02
Tyrothricine III SEP / 98
Ubiquinone U DEC / 98
Ulipristal or its salts or derivativesPDL I DEC / 13
Umeclidinium or its salts or derivativesPDL I FEB / 14
Uracil and its saltsF1 when sold for the treatment of cancer I DEC / 11
Uracil mustard or its saltsPDL I DEC / 13
Urea in topical preparations in concentrations of more than 25% II SEP / 98
UrokinasePDL I DEC / 13
Ursodeoxycholic acid or its saltsPDL I DEC / 13
UstekinumabPDL I DEC / 13
Vaccines (except for - those which are part of a routine immunization program in most/all provinces and territories: Diphtheria toxoid, Tetanus toxoid, Pertussis, Poliomyelitis, Haemophilus influenza type B, Measles, Mumps, Pneumococcus, Rubella, Hepatitis B Pediatric, Influenza, cholera vaccine (oral, inactivated) when used for prophylaxis against traveller's diarrhea & due to enterotoxigenic escherichia coli (ETEC); and those requiring special enhanced public access due to disease outbreaks: Meningococcus) I FEB / 02
Vaccines. which are part of a routine immunization program in most/all provinces and territories: Diptheria toxoid, Tetanus toxoid, Pertussis, Poliomyelitis, Haemophilus influenza type B, Measles, Mumps, Pneumococcus, Rubella, Hepatitis B Pediatric, Influenza, cholera vaccine (oral, inactivated) when used for prophylaxis against traveller's diarrhea & due to enterotoxigenic escherichia coli (ETEC); and those requiring special enhanced public access due to disease outbreaks: Meningococcus II FEB / 02
Valaciclovir or its saltsPDL I DEC / 13
Valdecoxib or its saltsPDL I DEC / 13
Valganciclovir or its salts or derivativesPDL I DEC / 13
Valproic acid or its saltsPDL

Including but not limited to Divalproex sodium

I DEC / 13
Valrubicin or its derivativesPDL I DEC / 13
Valsartan or its salts or derivativesPDL I DEC / 13
Vancomycin or its salts or derivativesPDL

including but not limited to Telavancin

I DEC / 13
Vandetanib or its salts or derivativesPDL I DEC / 13
Vardenafil or its saltsPDL I DEC / 13
Varenicline or its saltsPDL I DEC / 13
Varicella Zoster immune globulin I FEB / 02
Varicella vaccine (chicken pox) I FEB / 02
Vasopressin or its saltsPDL I DEC / 13
Vecuronium bromidePDL I DEC / 13
Vedaprofen or its salts or derivativesPDL I DEC / 13
VedolizumabPDL I MAR / 15
Vegetable tar except shampoos in concentrations of 5% or less III SEP / 98
Velaglucerase alfaPDL I DEC / 13
VelpatasvirPDL I AUG / 16
Vemurafenib or its salts or derivativesPDL I DEC / 13
Venetoclax or its saltsPDL I NOV / 16
Venlafaxine or its saltsPDL I DEC / 13
Verapamil or its saltsPDL I DEC / 13
Veratrum album or its alkaloids or their saltsPDL

for human use

I DEC / 13
Veratrum viride or its alkaloids or their saltsPDL

For human use

I DEC / 13
Vernakalant or its saltsPDL I APR / 17
Verteporfin or its salts or derivatives PDL I DEC / 13
VidarabinePDL I DEC / 13
Vigabatrin or its salts or derivativesPDL I DEC / 13
Vilanterol or its saltsPDL

Including but not limited to Vilaterol trifenatate

I DEC / 13
Vilazodone or its saltsPDL I AUG / 15
VinbarbitalC2 I JUN / 02
Vinblastine or its saltsPDL I DEC / 13
Vincristine or its saltsPDL I DEC / 13
Vindesine or its saltsPDL I DEC / 13
Vinorelbine or its saltsPDL I DEC / 13
VinylbitalC2 I JUN / 02
Viomycin or its salts or derivativesPDL I DEC / 13
Virginiamycin or its salts or derivativesPDL I DEC / 18
VismodegibPDL I DEC / 13
Vitamin APDL

in oral dosage forms containing more than 10,000 International Units of Vitamin A per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 10,000 International Units of Vitamin A for human use

I DEC / 13
Vitamin B12 with Intrinsic Factor ConcentratePDL I DEC / 13
Vitamin DPDL

For human use in oral dosage form containing more than 1,000 International Units of Vitamin D per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 1,000 International Units of Vitamin D

I DEC / 13
Vitamin KPDL

except Vitamin K1 and Vitamin K2 sold (a) for external use in humans; or (b) in an oral dosage form for use in humans if the maximum recommended daily dose is 0.120 mg or less For human use

I DEC / 13
Vitamins any parenterals not otherwise included in Schedule I II SEP / 98
Vitamins in injectable form for parenteral nutrition I JAN / 03
Vorapaxar or its saltsPDL I AUG / 16
VoriconazolePDL I DEC / 13
VorinostatPDL I DEC / 13
Vortioxetine or its saltsPDL

including but not limited to vortioxetine hydrobromide

I DEC / 14
Voxilaprevir or its saltsPDL I SEP / 17
Xanthinol nicotinatePDL I DEC / 13
Xylazine or its saltsPDL I DEC / 13
Xylometazoline and it salts in nasal preparations for pediatric use (0.05%) II SEP / 98
Xylometazoline and its salts in nasal preparations for adults (0.1%) U
Xylose II SEP / 98
Yellow Fever vaccine I FEB / 02
Yohimbine or its saltsPDL I DEC / 13

2020 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled